世界におけるがん免疫療法及びパイプラインインサイト...市場調査レポートについてご紹介

【英文タイトル】Cancer Immunotherapy Market & Clinical Pipeline Insight

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
世界におけるがん免疫療法及びパイプラインインサイト (Code:KUK40723)

【レポートの概要(一部)】

With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by almost all the economies of the world. Inspite of the fact that there have been significant improvisation and advancements in surgery, radiation therapy, and chemotherapy over the years, there has hardly been any significant control of this disease by these treatments. There have been many developments in the recent past, in terms of introducing novel methods of treatment of cancer, which are likely to have a great potential. Cancer immunotherapy is one such development in the field of cancer treatment. This treatment option involves manipulating the human body’s immune system in order to target the cancer.

The recent years have witnessed the emergence of cancer immunotherapy, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past 15-20 years, the researchers have increased their learning about the human body’s immune system, which has led to the achievement of significant number of regulatory milestones during this period. Cancer immunotherapy has been made commercial and the market availability of the agents has enabled the pharmaceutical companies to develop novel combination approaches which have the capability to provide even greater insight into the body’s immune system.

There has been some extensive research in the previous decade which has led to the development of vital novel therapies for diseases such as bladder cancer, renal cell carcinoma, colon cancer, and some leukemias. Additionally, these significant achievements in cancer immunotherapy have been popular on similar lines as improved techniques such as genetic engineering and monoclonal antibody generation. Thus, both these set of advancements have been working hand-in-hand to bring the cancer immunotherapy on the growth trajectory. The future is also likely to witness a continued close association between these two fields of advancements.

Cancer immunotherapy will continue to be overflowing with huge potential as a result of an increasing number of new discoveries and techniques. Inspite of advances being made in terms of understanding of the complexities of the human immune system, as compared to the state of immunology during Dr. Coley, there is still significant work which needs to be done. The complete detailed understanding is yet to be deciphered, which is one of the major reasons for cancer immunotherapy not being in widespread use.

“Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights:
• Cancer Immunotherapy Market Overview
• Cancer Immunotherapy Market Dynamics
• Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline
• Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country
• Cancer Vaccine Clinical Pipeline by Phase & Country
• Oncolytic Viruses Clinical Pipeline by Phase & Country
• Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country
• Cancer Cell Therapy Clinical Trial Insight by Phase & Country
• Currently there are 605 Cancer Monoclonal Antibodies, 289 Cancer Vaccines, 40 Oncolytic Viruses Drugs, 64 Cytokines Therapies & 82 Cell Therapies are in Clinical Pipeline

.....

【日本語概要(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポートの目次(一部)】

1. Introduction to Cancer Immunotherapy (Page 6)

2. Mechanism of Cancer Immunotherapy (Page 11)
2.1 Genetic engineering
2.2 Hybridoma Technology
2.3 Humanization of Monoclonal Antibodies
2.4 Overcoming the HAMA Response via Modern Technology

3. Types of Cancer Immunotherapy (Page 14)
3.1 Monoclonal Antibodies
3.2 Checkpoint Inhibitors
3.3 Vaccination
3.4 Non Specific Immunotherapies

4. Why Need for Cancer Immunotherapy (Page 23)

5. Global Cancer Immunotherapy Market Overview (Page 26)

6. Cancer Immunotherapy Market Dynamics (Page 33)
6.1 Favorable Market Drivers
6.2 Key issues to be Discussed
6.3 Future of Cancer Immunotherapy

7. Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country (Page 41)
7.1 Clinical Pipeline Overview
7.2 Clinical Pipeline Insight: Research till Registration
7.3 Marketed Cancer Monoclonal Antibodies

8. Cancer Vaccine Clinical Pipeline by Phase & Country (Page 1088)
8.1 Clinical Pipeline Overview
8.2 Clinical Pipeline Insight: Research till Registration
8.3 Marketed Cancer Vaccines

9. Oncolytic Viruses Clinical Pipeline by Phase & Country (Page 1640)
9.1 Clinical Pipeline Overview
9.2 Clinical Pipeline insight: Research till Registration

10. Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country (Page 1714)
10.1 Clinical Pipeline Overview
10.2 Clinical Pipeline Insight: Research till Preregistration
10.3 Marketed Cancer Cytokines Threapy

11. Cancer Cell Therapy Clinical Trial Insight by Phase & Country (Page 1844)
11.1 Clinical Pipeline Overview
11.2 Clinical Pipeline Insight: Research till Preregistration
11.3 Marketed Cancer Cell Therapy

12. Competitive Landscape: Business Overview & Product Pipeline (Page 1977)
12.1 Advaxis
12.2 Celldex Therapeutics
12.3 Dendreon Corporation
12.4 Galena Biopharma
12.5 ImmunoCellular Therapeutics
12.6 ImmunoGen
12.7 Inovio Pharmaceuticals
12.8 Merck
12.9 NeoStem Oncology
12.10 NewLink Genetics
12.11 Northwest Biotherapeutics
12.12 Novartis
12.13 Peregrine Pharmaceuticals
12.14 Roche
12.15 Seattle Genetics

List of Figures

Figure 1-1: Introduction to Cancer Therapies
Figure 1-2: Key Events in the History of Cancer Immunotherapy
Figure 2-1: Mechanism of Cancer Immunotherapy
Figure 3-1: Type of Cancer Immunotherapy

Figure 5-1: Cancer Immunotherapy Market Category
Figure 5-2: Cancer Immunotherapy Market (US$ Billion), 2014-2020
Figure 5-3: Cancer Immunotherapy Market by Region (%), 2014 & 2020
Figure 5-4: Regulatory Milestones for Cancer Immunotherapy

Figure 7-1: Cancer Monoclonal Antibodies Clinical Pipeline by Phase (%), 2014
Figure 7-2: Cancer Monoclonal Antibodies Clinical Pipeline by Phase (Number), 2014

Figure 8-1: Cancer Vaccine Clinical Pipeline by Phase (%), 2014
Figure 8-2: Cancer Vaccine Clinical Pipeline by Phase (Number), 2014

Figure 9-1: Oncolytic Viruses Clinical Pipeline by Phase (%), 2014
Figure 9-2: Oncolytic Viruses Clinical Pipeline by Phase (Number), 2014

Figure 10-1: Cancer Cytokines Therapy Clinical Pipeline by Phase (%), 2014
Figure 10-2: Cancer Cytokines Therapy Clinical Pipeline by Phase (Number), 2014

Figure 11-1: Cancer Cell Therapy Clinical Pipeline by Phase (%), 2014
Figure 11-2: Cancer Cell Therapy Clinical Pipeline by Phase (Number), 2014

Figure 12-1: Advaxis Clinical Pipeline
Figure 12-2: Celldex Therapeutics Clinical Pipeline
Figure 12-3: Galena Biopharma Clinical Pipeline
Figure 12-4: ImmunoCellular Therapeutics Clinical Pipeline
Figure 12-5: ImmunoGen Clinical Pipeline
Figure 12-6: Inovio Pharmaceuticals Clinical Pipeline
Figure 12-7: NewLink Genetics Corporation Clinical Pipeline
Figure 12-8: Northwest Biotherapeutics Clinical Pipeline
Figure 12-9: Peregrine Pharmaceuticals Clinical Pipeline
Figure 12-10: Seattle Genetics Clinical Pipeline

.....

【日本語目次(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポート販売概要】

■ タイトル:世界におけるがん免疫療法及びパイプラインインサイト
■ 英文:Cancer Immunotherapy Market & Clinical Pipeline Insight
■ 発行日:2014年7月
■ 調査会社:Kuick Research
■ 商品コード:KUK40723
■ 調査対象地域:グローバル

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
世界におけるがん免疫療法及びパイプラインインサイト (Cancer Immunotherapy Market & Clinical Pipeline Insight / KUK40723)

  • グローバル3Dイメージング市場:Global 3D Imaging Market 2014-2018
    TechNavio's analysts forecast the Global 3D Imaging market to grow at a CAGR of 26.53 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for 3D technologies. The Global 3D Imaging market has also been witnessing the technological shift from 2D to 3D. However, the high cost of 3D imaging systems could pose a challenge to the growth …
  • 粘着付与剤(タッキファイヤー)の世界市場:合成粘着付与剤、天然粘着付与剤
    The tackifier market is projected to reach USD 3.56 Billion by 2020, at a CAGR of 4.8% from 2015 to 2020. The key factor responsible for the growth of the tackifiers market is the increased demand from the adhesives industry. Packaging is the largest end-use industry for tackifiers, wherein tackifiers are used in flexible packaging, cases, cartoons, labels, and envelopes, among others. The demand …
  • 世界のハイスループットスクリーニング(高速大量スクリーニング)市場動向及び予測(~2018)
    “Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market” In this report, the global high throughput screening (HTS) market has been segmented on the basis of technology, products, applications, end users, and geography. The label-free technology market is expected to grow at the highest CAGR of 11.1% from 201 …
  • 世界における小型自動車用ルーフシステム市場(2008-2028)
    This latest just-auto report edition offers a global review of the OE roof systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE roof systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prosp …
  • Fluorosilicic Acidの世界市場
    Fluorosilicic Acid (CAS 16961-83-4) Market Research Report 2013 presents comprehensive data on fluorosilicic acid markets globally and regionally (Europe, Asia, North America etc.) The report includes fluorosilicic acid description, covers its application areas and related patterns. It overviews fluorosilicic acid market, names fluorosilicic acid producers and indicates its suppliers. Besides, the …
  • 世界のタンポン(Tampons)市場動向(2014-2018)
    TechNavio's analysts forecast the Global Tampons market to grow at a CAGR of 6.10 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased awareness. The Global Tampons market has also been witnessing the increasing demand from emerging economies. However, the increasing vendor competition could pose a challenge to the growth of this market. Tec …
  • 日本の移動補助・運搬機器市場見通し(~2021)
    Japan Mobility Aids and Transportation Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Japan Mobility Aids and Transportation Equipment Market Outlook to 2021", provides key market data on the Japan Mobility Aids and Transportation Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segme …
  • 医療レポート:Idiopathic Pulmonary Fibrosis-疫学予測(~2022)
    EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Summary Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily in older adults and is associated with a histologic and/or radiologic pattern of usual interstitial pneumonia (NHLBI, 2011; Raghu et al., 2011). As a fatal disease that falls under the umbrell …
  • 世界のピアノ市場2015
    Global Piano Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Piano industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Piano market analysis is provided for the international markets including development trends, competitive landscape analysis, and …
  • バルブ及びマニホールドの世界市場2015-2019
    About Valves and Manifolds Instrumentation valves are devices widely used in industrial production processes to control the flow of fluids and gases. These valves can be controlled either physically or automatically. There are different types of valves according to the needs and demands of the production process. Industries worldwide are increasingly using valves because they enhance production ef …
  • Gantenerumab (Alzheimer’s Disease):市場予測と分析(~2022)
    Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic ther …
  • 世界のスピリッツ(蒸留酒)市場動向:ニュース・イベント(2014年5月)
    Synopsis The report provides a review of the latest news and key events in the global spirits market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global spirits market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global spirits …
  • ボロン酸アフィニティークロマトグラフィーの世界市場2016-2020
    About Affinity Chromatography Affinity chromatography is a separation method that utilizes the specific binding interaction between an immobilized ligand and its binding partner for separation and purification. Boronate affinity chromatography is based on the boronate functional group and used for the selective separation and molecular recognition of cis-diol-containing compounds in industries lik …
  • 動脈血栓症:治療薬のグローバル治験動向(2014年下半期)
    Arterial Thrombosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Arterial Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Arterial Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Thrombosis. It includes an overview of the trial numbers and their recru …
  • ワクチンの世界市場2016-2020
    About Human Vaccine According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. Human vaccines are of two types: prevent …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。